# ALPL

## Overview
The ALPL gene encodes the enzyme tissue-nonspecific alkaline phosphatase (TNAP), a Zn2+-metalloenzyme that plays a critical role in bone mineralization and phosphate metabolism. TNAP is categorized as a phosphatase, an enzyme that catalyzes the hydrolysis of phosphoesters, thereby regulating the levels of inorganic phosphate and pyrophosphate, which are essential for the formation of hydroxyapatite crystals in bone tissue (Whyte2010Physiological; Nakamura2020Tissuenonspecific). The enzyme is expressed predominantly in osteoblasts and is involved in various physiological processes, including osteogenic differentiation and vitamin B6 metabolism (Olde2018The). Mutations in the ALPL gene are associated with hypophosphatasia (HPP), a genetic disorder characterized by impaired bone and tooth mineralization, highlighting the clinical significance of this gene and its encoded enzyme (Sanabriade2022Characterization; Jandl2020Genotype–Phenotype).

## Structure
The ALPL gene encodes the tissue-nonspecific alkaline phosphatase (TNAP), a homodimeric enzyme involved in dephosphorylation processes crucial for bone mineralization. The primary structure of TNAP consists of a polypeptide chain with specific amino acid sequences that facilitate its enzymatic function. The secondary structure includes alpha-helices and beta-sheets, contributing to the enzyme's stability and function (Vimalraj2020Alkaline).

The tertiary structure of TNAP forms a compact, globular shape, which is essential for its interaction with substrates and inhibitors. The quaternary structure involves the dimerization of TNAP monomers, a process mediated by disulfide bonds, which is significant for the enzyme's function and can influence the severity of hypophosphatasia symptoms due to dominant-negative effects of ALPL mutations (Liedtke2020TissueNonspecific).

TNAP contains several functional domains, including the active site, the crown domain, and the calcium-binding domain. The crown domain is involved in stabilizing the positioning of inhibitors and determining isozyme-specific properties like heat stability and collagen binding (Buchet2013Multisystemic). Post-translational modifications, such as glycosylation, are crucial for TNAP's catalytic activities and stability, with the bone and liver isoforms differing in glycosylation patterns (Buchet2013Multisystemic).

## Function
The ALPL gene encodes tissue-nonspecific alkaline phosphatase (TNSALP), a Zn2+-metalloenzyme crucial for various physiological processes, particularly in bone mineralization and phosphate metabolism. TNSALP is highly expressed in osteoblasts, where it catalyzes the hydrolysis of phosphoesters and inorganic pyrophosphate (PPi) into inorganic phosphate (Pi), promoting the formation of hydroxyapatite crystals essential for bone mineralization (Whyte2010Physiological; Nakamura2020Tissuenonspecific). This enzyme is also involved in the osteogenic differentiation of osteoprogenitor cells by enhancing RUNX2-mediated gene expression, which is critical for osteoblast maturation (Nakamura2020Tissuenonspecific).

In mesenchymal stem cells (MSCs), ALPL regulates the osteo-adipogenic balance and prevents cell senescence by modulating ATP levels and the AMPKα pathway. ALPL deficiency leads to increased extracellular ATP, which inhibits osteogenesis and promotes adipogenesis, contributing to bone aging (Liu2018Alpl). TNSALP is also involved in vitamin B6 metabolism, hydrolyzing phosphorylated B6 vitamers for transport across cell membranes, which is crucial for maintaining vitamin B6 homeostasis in plasma and cerebrospinal fluid (Olde2018The). The enzyme's activity is modulated by posttranslational modifications, such as N-glycosylation, necessary for its catalytic function (Whyte2010Physiological).

## Clinical Significance
Mutations in the ALPL gene, which encodes the tissue-nonspecific alkaline phosphatase (TNSALP), are primarily associated with hypophosphatasia (HPP), a rare genetic disorder characterized by defective bone and tooth mineralization. HPP presents in various forms, ranging from severe perinatal cases to milder adult forms, with symptoms including bone and tooth mineralization disorders, musculoskeletal pain, and calcifications in tendons, joints, or kidneys (Sanabriade2022Characterization; Jandl2020Genotype–Phenotype). The disease is caused by loss-of-function mutations in the ALPL gene, leading to decreased enzyme activity and the accumulation of substrates like pyridoxal 5′-phosphate (PLP) and inorganic pyrophosphate (PPi) (Sanabriade2022Characterization; Masi2021Polymorphic).

The inheritance pattern of HPP can be autosomal dominant or recessive, with severe forms typically resulting from autosomal recessive inheritance. Milder forms may involve a dominant negative effect of a single heterozygous mutation (Tournis2021Hypophosphatasia). Clinical manifestations are highly variable due to the genetic heterogeneity of the ALPL gene, which has over 500 loss-of-function variants (Sanabriade2022Characterization). Genetic testing is crucial for diagnosing HPP, as not all ALPL variants result in the disease (Jandl2020Genotype–Phenotype).

## Interactions
The ALPL gene encodes the tissue-nonspecific alkaline phosphatase (TNAP), which participates in several physical interactions crucial for its function. TNAP interacts with type I collagen, which is believed to contribute to bone mineralization. This interaction is significant as mutations in the COL1A2 gene, encoding a component of type I collagen, have been identified as modifiers of hypophosphatasia (HPP) (Kato2021Novel). TNAP also interacts with osteopontin (OPN), a mineralization inhibitor, and ANKH, which mediates pyrophosphate channeling, both of which are involved in bone mineralization processes (Mornet2015Molecular).

The enzyme is part of a group of phosphatases, including prostatic acid phosphatase (PAP) and ecto-5'-nucleotidase (NT5E), that generate adenosine from AMP in neurons, influencing pain signaling (Mornet2015Molecular). TNAP's structure includes a crown domain that may be involved in binding to collagen, further stabilizing its dimeric structure (Mornet2015Molecular). These interactions highlight TNAP's role in mineralization and its potential involvement in other biological processes. The enzyme's activity is also influenced by its interactions with metal ions such as Zn2+ and Mg2+, which are crucial for its structural and functional integrity (Chen2017A).


## References


[1. (Whyte2010Physiological) Michael P. Whyte. Physiological role of alkaline phosphatase explored in hypophosphatasia. Annals of the New York Academy of Sciences, 1192(1):190–200, April 2010. URL: http://dx.doi.org/10.1111/j.1749-6632.2010.05387.x, doi:10.1111/j.1749-6632.2010.05387.x. This article has 280 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/j.1749-6632.2010.05387.x)

[2. (Kato2021Novel) Masaru Kato, Toshimi Michigami, Kanako Tachikawa, Momoko Kato, Ichiro Yabe, Tomohiro Shimizu, Takuya Asaka, Yoshimasa Kitagawa, and Tatsuya Atsumi. Novel mutation in the alpl gene with a dominant negative effect in a japanese family. Journal of Bone and Mineral Metabolism, 39(5):804–809, April 2021. URL: http://dx.doi.org/10.1007/s00774-021-01219-0, doi:10.1007/s00774-021-01219-0. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00774-021-01219-0)

[3. (Olde2018The) Loes M. Olde Loohuis, Monique Albersen, Simone De Jong, Timothy Wu, Jurjen J. Luykx, Judith J. M. Jans, Nanda M. Verhoeven-Duif, and Roel A. Ophoff. The alkaline phosphatase (alpl) locus is associated with b6 vitamer levels in csf and plasma. Genes, 10(1):8, December 2018. URL: http://dx.doi.org/10.3390/genes10010008, doi:10.3390/genes10010008. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes10010008)

[4. (Vimalraj2020Alkaline) Selvaraj Vimalraj. Alkaline phosphatase: structure, expression and its function in bone mineralization. Gene, 754:144855, September 2020. URL: http://dx.doi.org/10.1016/j.gene.2020.144855, doi:10.1016/j.gene.2020.144855. This article has 456 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.gene.2020.144855)

[5. (Liedtke2020TissueNonspecific) Daniel Liedtke, Christine Hofmann, Franz Jakob, Eva Klopocki, and Stephanie Graser. Tissue-nonspecific alkaline phosphatase—a gatekeeper of physiological conditions in health and a modulator of biological environments in disease. Biomolecules, 10(12):1648, December 2020. URL: http://dx.doi.org/10.3390/biom10121648, doi:10.3390/biom10121648. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biom10121648)

[6. (Masi2021Polymorphic) L. Masi, F. Marini, F. Franceschelli, G. Leoncini, L. Cianferotti, F. Cioppi, F. Giusti, G. Marcucci, G. Gronchi, and M. L. Brandi. Polymorphic variants of alkaline phosphatase gene correlate with clinical signs of adult hypophosphatasia? Osteoporosis International, 32(12):2461–2472, June 2021. URL: http://dx.doi.org/10.1007/s00198-021-05893-8, doi:10.1007/s00198-021-05893-8. This article has 5 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00198-021-05893-8)

[7. (Buchet2013Multisystemic) René Buchet, José Luis Millán, and David Magne. Multisystemic Functions of Alkaline Phosphatases, pages 27–51. Humana Press, 2013. URL: http://dx.doi.org/10.1007/978-1-62703-562-0_3, doi:10.1007/978-1-62703-562-0_3. This article has 138 citations.](https://doi.org/10.1007/978-1-62703-562-0_3)

[8. (Tournis2021Hypophosphatasia) Symeon Tournis, Maria Yavropoulou, Stergios Polyzos, and Artemis Doulgeraki. Hypophosphatasia. Journal of Clinical Medicine, 10(23):5676, December 2021. URL: http://dx.doi.org/10.3390/jcm10235676, doi:10.3390/jcm10235676. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/jcm10235676)

[9. (Sanabriade2022Characterization) Raquel Sanabria-de la Torre, Luis Martínez-Heredia, Sheila González-Salvatierra, Francisco Andújar-Vera, Iván Iglesias-Baena, Juan Miguel Villa-Suárez, Victoria Contreras-Bolívar, Mario Corbacho-Soto, Gonzalo Martínez-Navajas, Pedro J. Real, Cristina García-Fontana, Manuel Muñoz-Torres, and Beatriz García-Fontana. Characterization of genetic variants of uncertain significance for the alpl gene in patients with adult hypophosphatasia. Frontiers in Endocrinology, April 2022. URL: http://dx.doi.org/10.3389/fendo.2022.863940, doi:10.3389/fendo.2022.863940. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fendo.2022.863940)

[10. (Chen2017A) Bin Chen, Lili Li, Weitong Ren, Long Yi, Yaping Wang, and Fuhua Yan. A novel missense mutation in the alpl gene causes dysfunction of the protein. Molecular Medicine Reports, 16(1):710–718, January 2017. URL: http://dx.doi.org/10.3892/mmr.2017.6668, doi:10.3892/mmr.2017.6668. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2017.6668)

[11. (Nakamura2020Tissuenonspecific) Takashi Nakamura, Aki Nakamura-Takahashi, Masataka Kasahara, Akira Yamaguchi, and Toshifumi Azuma. Tissue-nonspecific alkaline phosphatase promotes the osteogenic differentiation of osteoprogenitor cells. Biochemical and Biophysical Research Communications, 524(3):702–709, April 2020. URL: http://dx.doi.org/10.1016/j.bbrc.2020.01.136, doi:10.1016/j.bbrc.2020.01.136. This article has 55 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2020.01.136)

[12. (Jandl2020Genotype–Phenotype) Nico Maximilian Jandl, Tobias Schmidt, Tim Rolvien, Julian Stürznickel, Konstantin Chrysostomou, Emil von Vopelius, Alexander E. Volk, Thorsten Schinke, Christian Kubisch, Michael Amling, and Florian Barvencik. Genotype–phenotype associations in 72 adults with suspected alpl-associated hypophosphatasia. Calcified Tissue International, 108(3):288–301, November 2020. URL: http://dx.doi.org/10.1007/s00223-020-00771-7, doi:10.1007/s00223-020-00771-7. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00223-020-00771-7)

[13. (Liu2018Alpl) Wenjia Liu, Liqiang Zhang, Kun Xuan, Chenghu Hu, Shiyu Liu, Li Liao, Bei Li, Fang Jin, Songtao Shi, and Yan Jin. Alpl prevents bone ageing sensitivity by specifically regulating senescence and differentiation in mesenchymal stem cells. Bone Research, September 2018. URL: http://dx.doi.org/10.1038/s41413-018-0029-4, doi:10.1038/s41413-018-0029-4. This article has 60 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41413-018-0029-4)

[14. (Mornet2015Molecular) Etienne Mornet. Molecular Genetics of Hypophosphatasia and Phenotype-Genotype Correlations, pages 25–43. Springer Netherlands, 2015. URL: http://dx.doi.org/10.1007/978-94-017-7197-9_2, doi:10.1007/978-94-017-7197-9_2. This article has 41 citations.](https://doi.org/10.1007/978-94-017-7197-9_2)